Jinyan Lin Selected Research

Jinyan Lin Research Topics

Disease

30	Neoplasms (Cancer) 02/2022 - 01/2013
4	Hypoxia (Hypoxemia) 01/2022 - 12/2019
4	Infections 01/2021 - 01/2013
2	Human Influenza (Influenza) 06/2015 - 12/2014
1	Rupture 01/2022
1	Brain Hypoxia (Cerebral Hypoxia) 01/2021
1	Gangrene 01/2021
1	Ulcer 01/2021
1	Wounds and Injuries (Trauma) 01/2021
1	Sepsis (Septicemia) 01/2021
1	Familial Primary Pulmonary Hypertension 01/2021
1	Thrombosis (Thrombus) 12/2019
1	Dengue (Dengue Fever) 01/2016
1	Acquired Immunodeficiency Syndrome (AIDS) 06/2015
1	Pneumonia (Pneumonitis) 12/2014
1	Hemolysis 08/2014
1	Hepatocellular Carcinoma (Hepatoma) 01/2013
1	Body Weight (Weight, Body) 01/2013

Drug/Important Bio-Agent (IBA)

17	Pharmaceutical PreparationsIBA 01/2021 - 01/2013
7	Methotrexate (Mexate)FDA LinkGeneric 06/2018 - 01/2014
7	Folic Acid (Vitamin M)FDA LinkGeneric 11/2017 - 01/2014
6	LigandsIBA 02/2021 - 01/2014
3	Peptides (Polypeptides)IBA 02/2022 - 06/2015
3	Therapeutic UsesIBA 02/2021 - 07/2014
3	ProdrugsIBA 10/2016 - 06/2015
3	Mitomycin (Mitomycin-C)FDA LinkGeneric 08/2015 - 01/2014
3	ChitosanIBA 06/2015 - 01/2014
3	Drug CarriersIBA 08/2014 - 01/2014
2	Follicle Stimulating Hormone (Follitropin)FDA Link 02/2022 - 01/2020
2	ketohexokinaseIBA 01/2022 - 01/2021
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 08/2020
2	Sulfhydryl Compounds (Thiols)IBA 01/2022 - 01/2022
2	FructoseIBA 01/2022 - 01/2021
2	Explosive Agents (Explosives)IBA 01/2022 - 01/2016
2	Glutathione (Reduced Glutathione)IBA 01/2022 - 01/2022
2	Antineoplastic Agents (Antineoplastics)IBA 08/2020 - 01/2014
2	Proteins (Proteins, Gene)FDA Link 08/2020 - 01/2018
2	10-hydroxycamptothecinIBA 06/2018 - 03/2015
2	Phospholipids (Phosphatides)FDA LinkGeneric 06/2018 - 08/2015
2	Hyaluronic Acid (Hyaluronan)IBA 06/2018 - 09/2017
2	homocamptothecinIBA 06/2018 - 03/2015
2	Nucleic AcidsIBA 01/2018 - 01/2016
2	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 10/2017 - 11/2015
2	Coloring Agents (Dyes)IBA 10/2015 - 06/2015
2	PhytosomesIBA 09/2014 - 01/2013
1	Adenosine Triphosphatases (ATPase)IBA 01/2022
1	Fructose-Bisphosphate Aldolase (Aldolase)IBA 01/2022
1	16S Ribosomal RNAIBA 01/2022
1	DisulfidesIBA 01/2022
1	CarbohydratesIBA 01/2022
1	IonsIBA 01/2022
1	Free RadicalsIBA 01/2022
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	EnzymesIBA 01/2021
1	Gentamicins (Gentamicin)FDA LinkGeneric 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	Proteoglycans (Proteoglycan)IBA 01/2021
1	Silicon Dioxide (Silica)FDA LinkGeneric 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	Eukaryotic Initiation Factor-4EIBA 01/2021
1	Oxygen (Dioxygen)IBA 08/2020
1	Paclitaxel (Taxol)FDA LinkGeneric 08/2020
1	Messenger RNA (mRNA)IBA 12/2019
1	Fibrinogen (Factor I)FDA Link 12/2019
1	MetalsIBA 11/2019
1	AntimetabolitesIBA 06/2018
1	AlkaloidsIBA 06/2018
1	AmidesIBA 11/2017
1	IminesIBA 11/2017
1	stearylamineIBA 09/2017
1	CurcuminIBA 09/2017
1	SolutionsIBA 09/2017
1	1,2-distearoylphosphatidylethanolamine (DSPE)IBA 08/2015
1	poly(ethylene glycol)-folateIBA 08/2015
1	Peptide Hydrolases (Proteases)FDA Link 06/2015
1	ferric oxide (iron oxide)IBA 06/2015
1	Influenza Vaccines (Influenza Vaccine)FDA Link 06/2015
1	PolymersIBA 04/2015
1	methoxy poly(ethylene glycol)-poly(lactide)IBA 04/2015
1	MicellesIBA 03/2015
1	chenodeoxycholate sulfate conjugate (CDCS)IBA 12/2014
1	dioleoyl-N-(monomethoxypolyethylene glycol succinyl)phosphatidylethanolamineIBA 08/2014
1	VaccinesIBA 01/2013

Therapy/Procedure

14	Therapeutics 01/2022 - 01/2013
10	Drug Therapy (Chemotherapy) 02/2021 - 07/2014
3	Lasers (Laser) 01/2022 - 01/2017
2	Nanospheres 11/2015 - 10/2015
1	Combination Drug Therapy (Combination Chemotherapy) 11/2017